Search for: "Lay v. USA"
Results 41 - 60
of 298
Sort by Relevance
|
Sort by Date
17 Jun 2021, 9:01 pm
In Fulton v. [read post]
7 Jun 2021, 7:42 am
Frito-Lay North America, Inc, March 17, 2021, Wynn, J.). [read post]
7 Jun 2021, 7:42 am
Frito-Lay North America, Inc, March 17, 2021, Wynn, J.). [read post]
28 May 2021, 6:03 am
From Burke v. [read post]
12 Apr 2021, 7:05 am
” The Federal Circuit also held that the defendants were entitled to sanctions in the form of appellate attorney fees and double costs, against both the complaining individual and his legal counsel (Pirri v. [read post]
8 Apr 2021, 9:52 am
Justice Breyer’s opinion does a good job of laying out the facts (slip op. at 1-9) and the procedure posture (slip op. at 9-11). [read post]
5 Apr 2021, 7:49 am
See also Ingate v. [read post]
3 Mar 2021, 12:39 am
Another topic to evaluate is how patent protection strategies are pursued in parallel to clinical and commercial activities related to COVID-19 vaccines, diagnostics, and therapeutics (for example, the authors of a recent Lancet paper about the Sputnik V vaccine are named as inventors in a series of Russian patent documents published between May and September 2020 and in a PCT application published in January 2021). [read post]
8 Jan 2021, 10:17 am
Eligibility generally is limited to low-income households and those who have endured lay-offs or furloughs. [read post]
11 Dec 2020, 3:11 am
On 4 December 2020, the English Patents Court handed down its decision in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited, the main action proceedings regarding Neurim’s patent for Circadin, EP 1 441 702 (“EP 702”). [read post]
22 Nov 2020, 5:43 pm
This memo was written for an upcoming workers’ compensation trial. [read post]
20 Nov 2020, 9:36 pm
In Kestel v. [read post]
12 Nov 2020, 1:38 pm
Miller (Wikipedia) U.S. v. [read post]
28 Oct 2020, 6:49 am
Jude Medical, LLC v. [read post]
9 Oct 2020, 4:47 am
The patent owner did not establish that the Board erred in its finding that the challenged claims were obvious in light of the prior art (Siemens Mobility, Inc. v. [read post]
29 Aug 2020, 9:49 pm
” These declarations alleged only “possible future injury” and failed to establish a substantial risk of harm (Association for Accessible Medicines v. [read post]
3 Aug 2020, 9:01 pm
James School v. [read post]
14 Jul 2020, 8:11 am
Nor did the Board err by considering design drawings submitted by the review petitioner as proof of design elements that were known in the art at the critical time of the challenged patents (B/E Aerospace, Inc. v. [read post]
10 Jul 2020, 5:21 pm
Mazars USA, LLP, involved subpoenas from the House of Representatives. [read post]
16 Jun 2020, 2:18 pm
John Reed StarkIs a company’s post-breach forensic report subject to discovery in subsequent breach related litigation? [read post]
